Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Establishment of a Patient-Centered Outcomes Research Network for Individuals with TBI and Neuropsychiatric Symptoms.

Rao VA, Bechtold KT, Arciniegas DB, Samus QM, Albrecht J, Pugh BT, Jacoby A, Buenaver L.

Brain Inj. 2020 Feb 12:1-8. doi: 10.1080/02699052.2020.1725980. [Epub ahead of print]

PMID:
32050805
2.

Age differences in outcome after mild traumatic brain injury: results from the HeadSMART study.

Richey LN, Rao V, Roy D, Narapareddy BR, Wigh S, Bechtold KT, Sair HI, Van Meter TE, Falk H, Leoutsakos JM, Yan H, Lyketsos CG, Korley FK, Peters ME.

Int Rev Psychiatry. 2020 Feb;32(1):22-30. doi: 10.1080/09540261.2019.1657076. Epub 2019 Sep 24.

PMID:
31549522
3.

Clinical Gestalt for Early Prediction of Delayed Functional and Symptomatic Recovery From Mild Traumatic Brain Injury Is Inadequate.

Korley FK, Peacock WF, Eckner JT, Maio R, Levin S, Bechtold KT, Peters M, Roy D, Falk HJ, Hall AJ, Van Meter TE, Gonzalez R, Diaz-Arrastia R.

Acad Emerg Med. 2019 Dec;26(12):1384-1387. doi: 10.1111/acem.13844. Epub 2019 Sep 5. No abstract available.

PMID:
31397520
4.

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET.

Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES, Rosenthal HB, Reekie TA, Kassiou M, Dannals RF, Soloski MJ, Aucott JN, Pomper MG.

J Neuroinflammation. 2018 Dec 19;15(1):346. doi: 10.1186/s12974-018-1381-4.

5.

Influence of study population definition on the effect of age on outcomes after blunt head trauma.

Peters ME, Hsu M, Rao V, Roy D, Narapareddy BR, Bechtold KT, Sair HI, Van Meter TE, Falk H, Hall AJ, Lyketsos CG, Korley FK.

Brain Inj. 2018;32(13-14):1725-1730. doi: 10.1080/02699052.2018.1520301. Epub 2018 Sep 19.

6.

Cognitive Decline in Post-treatment Lyme Disease Syndrome.

Touradji P, Aucott JN, Yang T, Rebman AW, Bechtold KT.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):455-465. doi: 10.1093/arclin/acy051.

PMID:
29945190
7.

Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.

Weinstein ER, Rebman AW, Aucott JN, Johnson-Greene D, Bechtold KT.

Sleep. 2018 May 1;41(5). doi: 10.1093/sleep/zsy035.

PMID:
29452400
8.

The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN.

Front Med (Lausanne). 2017 Dec 14;4:224. doi: 10.3389/fmed.2017.00224. eCollection 2017.

9.

Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.

PMID:
28365751
10.

Head injury serum markers for assessing response to trauma: Design of the HeadSMART study.

Peters ME, Rao V, Bechtold KT, Roy D, Sair HI, Leoutsakos JM, Diaz-Arrastia R, Stevens RD, Batty DS Jr, Falk H, Fernandez C, Ofoche U, Vassila A, Hall AJ, Anderson B, Bessman E, Lyketsos CG, Everett AD, Van Eyk J, Korley FK.

Brain Inj. 2017;31(3):370-378. doi: 10.1080/02699052.2016.1231344. Epub 2017 Jan 31.

11.

Embedded performance validity testing in neuropsychological assessment: Potential clinical tools.

Rickards TA, Cranston CC, Touradji P, Bechtold KT.

Appl Neuropsychol Adult. 2018 May-Jun;25(3):219-230. doi: 10.1080/23279095.2017.1278602. Epub 2017 Jan 31. Review.

PMID:
28139144
12.

Role of resilience in the rehabilitation of adults with acquired brain injury.

Neils-Strunjas J, Paul D, Clark AN, Mudar R, Duff MC, Waldron-Perrine B, Bechtold KT.

Brain Inj. 2017;31(2):131-139. doi: 10.1080/02699052.2016.1229032. Epub 2017 Jan 5. Review.

PMID:
28055235
13.

Prevalence of Incomplete Functional and Symptomatic Recovery among Patients with Head Injury but Brain Injury Debatable.

Korley FK, Diaz-Arrastia R, Falk HJ, Peters ME, Leoutsakos JS, Roy D, Rao V, Sair HI, Ofoche U, Hall AJ, Akbari F, Van Meter TE, Everett AD, Van Eyk JE, Bechtold KT.

J Neurotrauma. 2017 Apr 15;34(8):1531-1538. doi: 10.1089/neu.2016.4723. Epub 2016 Dec 20.

PMID:
27784200
14.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

15.

The role of psychological facilitators and barriers to therapeutic engagement in acute, inpatient rehabilitation.

Ramanathan-Elion DM, McWhorter JW, Wegener ST, Bechtold KT.

Rehabil Psychol. 2016 Aug;61(3):277-287. doi: 10.1037/rep0000095. Epub 2016 May 12.

PMID:
27177212
16.

Living in Limbo: Contested Narratives of Patients With Chronic Symptoms Following Lyme Disease.

Rebman AW, Aucott JN, Weinstein ER, Bechtold KT, Smith KC, Leonard L.

Qual Health Res. 2017 Mar;27(4):534-546. doi: 10.1177/1049732315619380. Epub 2016 Jul 10.

PMID:
26631681
17.

Increased Rates of Mild Traumatic Brain Injury Among Older Adults in US Emergency Departments, 2009-2010.

Albrecht JS, Hirshon JM, McCunn M, Bechtold KT, Rao V, Simoni-Wastila L, Smith GS.

J Head Trauma Rehabil. 2016 Sep-Oct;31(5):E1-7. doi: 10.1097/HTR.0000000000000190.

18.

Who are tomboys and why should we study them?

Bailey JM, Bechtold KT, Berenbaum SA.

Arch Sex Behav. 2002 Aug;31(4):333-41.

PMID:
12187546
19.

Ethical considerations for peer review in forensic neuropsychology.

Johnson-Greene D, Bechtold KT.

Clin Neuropsychol. 2002 Feb;16(1):97-104.

PMID:
11992232
20.

The construct validity and clinical utility of the Frank Jones story as a brief screening measure of cognitive dysfunction.

Bechtold KT, Horner MD, Labbate LA, Windham WK.

Psychosomatics. 2001 Mar-Apr;42(2):146-9.

PMID:
11239128

Supplemental Content

Loading ...
Support Center